Treprostinil sodium (Synonyms: 曲前列尼尔钠; UT-15 sodium)
目录号: PL10116 纯度: ≥98.0%
CAS No. :289480-64-4
商品编号 规格 价格 会员价 是否有货 数量
PL10116-1mg 1mg ¥1237.00 请登录
PL10116-5mg 5mg ¥3857.00 请登录
PL10116-10mg 10mg ¥6589.00 请登录
PL10116-25mg 25mg ¥14144.00 请登录
PL10116-50mg 50mg 询价 询价
PL10116-100mg 100mg 询价 询价
PL10116-10mM*1mLinDMSO 10mM*1mLinDMSO ¥3500.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Treprostinil sodium
中文别名
曲前列尼尔钠;曲前列素;曲前列尼尔钠289480-64-4,工厂零售289480-64-4;曲列前素;曲前列尼尔钠9(瑞莫杜林) 1G;曲前列尼尔钠9(瑞莫杜林);曲前列尼尔酸;曲前列环素钠盐
英文名称
Treprostinil sodium
英文别名
Treprostinil sodium;REMODULIN;sodium,2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetate;UT-15;15AU81;Tyvaso;UNII-7JZ75N2NT6;Uniprost;UT 15;UT 15 (pharmaceutical);AK543398;CID 138107805;Treprostinil Sodium API;Treprostinil Sodium (UT-15);UT 15 (pharMaceutical);Treprostinil sodium salt;289480-64-4 Treprostinil Sodium;Treprostinil sodium (LRX15);Treprostinil 13C2 D1 Sodium SaltQ: What is Treprostinil 13C2 D1 Sodium Salt Q: What is the CAS Number of Treprostinil 13C2 D1 Sodium Salt Q: What is the storage condition of Treprostinil 13C2 D1 Sodium Salt Q: What are the applications of Treprostinil 13C2 D1 Sodium Salt;2-(((1R,2R,3aS,9aS)-2-Hydroxy-1-((S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-5-yl)oxy)acetic acid, sodium salt;Remodulin
Cas No.
289480-64-4
分子式
C23H33NaO5
分子量
412.49
包装储存
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
产品详情
Treprostinil (UT-15) sodium 是高效的DP1和EP2激动剂,其EC50值分别为0.6±0.1和6.2±1.2 nM。
生物活性
Treprostinil (UT-15) sodium is a potent DP1 and EP2 agonist with EC 50 values of 0.6±0.1 and 6.2±1.2 nM, respectively.
性状
Solid
IC50 & Target[1][2]
IP Receptor 1.9 nM (EC50) TP Receptor 919
体外研究(In Vitro)
Treprostinil sodium has high affinity for the DP1, EP2 and IP receptors (Ki=4.4, 3.6 and 32 nM, respectively), low affinity for EP1 and EP4 receptors and even lower affinity for EP3, FP and TP receptors. Activation of IP, DP1 and EP2 receptors, as with treprostinil, can all result in vasodilatation of human pulmonary arteries.Treprostinil sodium inhibits viability of cultured endothelial colony forming cells. Endothelial colony forming cells proliferation is stimulated by conditioned media from Treprostinil pretreated mesenchymal stem cells. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Inhaled treprostinil sodium, a prostacyclin analog, is the most recent agent to receive FDA approval for the treatment of a fatal orphan disease: pulmonary arterial hypertension (PAH). Treprostinil preserves the sinusoidal endothelial cell lining and reduces platelet deposition early post-transplantation compared to placebo. Hepatic tissue blood flow is significantly compromised in the placebo group, whereas treprostinil maintains blood flow similar to normal levels.Treprostinil treatment significantly increases the vessel-forming ability of endothelial colony forming cells combined with mesenchymal stem cells in Matrigel implanted in nude mice. Silencing VEGF-A gene in mesenchymal stem cells also blocks the pro-angiogenic effect of Treprostinil. Treprostinil is most efficacious in raising intracellular cAMP levels in murine and human hematopoietic stem and progenitor cells. T
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
ClinicalTrial
参考文献
[1]. Whittle BJ, et al. Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist. Biochem Pharmacol. 2012 Jul 1;84(1):68-75.
[2]. Smadja DM, et al. Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells. Thromb Haemost. 2015 Oct;114(4):735-47.
溶解度数据
In Vitro: DMSO : ≥ 26 mg/mL (63.03 mM)H2O : 16.67 mg/mL (40.41 mM; Need ultrasonic)
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2